Shufro Rose & Co’s Boston Scientific BSX Stock Holding History

Shufro Rose & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$841K	Buy	+19,700	New	+$1.07M	0.05%	140

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Shufro Rose & Co's BSX Position: Q2 2026 in Review

Shufro Rose & Co opened a new position in Boston Scientific (BSX) in Q2 2026: 19,700 shares worth $841K. The stake represents 0.05% of the portfolio and ranks #140 among its holdings.

1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Shufro Rose & Co held 19,700 shares of Boston Scientific worth $841K as of Q2 2026.
Boston Scientific was a new Shufro Rose & Co position in Q2 2026.
Boston Scientific made up 0.05% of Shufro Rose & Co's portfolio in Q2 2026, its #140 holding.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Shufro Rose & Co's 13F filing for Q2 2026, filed 12 Aug 2026.